QA: Reviva Pharmaceuticals Holdings INC in us_pharma/2024

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001742927_2025_Reviva_Pharmaceuticals_Holdings_INC.pdf

Logs

warning Missing logo subcommand.report {}

Graph

Absolute values for 0001742927, Reviva Pharmaceuticals Holdings INC

  xvar xval
0 AssetsCurrent 14,683,367
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 819,721
4 LiabilitiesCurrent 14,601,506
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 89,010
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 7,779,935
9 ResearchAndDevelopmentExpense 20,055,041
10 remainder_Expenses 19,072
11 remainder_Revenues 0
12 remainder_NetIncome 1,009,013
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 15,503,088
1 Liabilities 14,690,516
2 Expenses 27,854,048
3 Revenues 0
4 StockholdersEquity 812,572
5 NetIncome -26,845,035
6 ComprehensiveNetIncome -26,845,035
7 BaseVar 29,528,332
8 EconomicCapitalRatiobeforeLimitedLiability -1.66
9 EconomicCapitalRatio 1.13

Edgar->Model Mapping

Feature Distribution

Change over Time